Equity Briefing: Bullish Sentiment Continues For Canada's Neptune

Appearing earlier this week on the show MarketSense-- which is featured on the Business News Network: Canada's only all-business and financial news television channel-- Alex Ruus, VP & Portfolio Manager at BluMont Capital referred to Neptune Technologies & Bioresources, Inc. (NASDAQ:NEPT) as a top pick and stated: "This (Neptune) could be a 10 bagger type stock...

Appearing earlier this week on the show MarketSense-- which is featured on the Business News Network: Canada's only all-business and financial news television channel-- Alex Ruus, VP & Portfolio Manager at BluMont Capital referred to Neptune Technologies & Bioresources, Inc. (NASDAQ:NEPT) as a top pick and stated: "This (Neptune) could be a 10 bagger type stock." 

During the interview, Russ mentioned the Phase Two clinical trials at Neptune subsidiary, Acasti Pharma and explained that the exploratory medical analysis of its potential drug candidate, CaPre-- currently in phase II clinical studies in patients with hypertriglyceridemia-- are going very well.

"We expect some big news coming out of the company later on this year, which will catapult this stock to all time highs," Said Russ. Shares of Neptune traded at an all time high of just over $8 back in 2007.

The sentiment follows last Friday afternoon's BNN appearance of Byron Capital's Health Care Analyst, Doug Loe who also named Neptune as one of his Top Picks on BNN.

Mr. Loe reiterated his $6 buy target on the stock and sites Neptune's record revenues over the last three quarters, he discussed the current Acasti clinical studies as well.


Source: http://bit.ly/KwcE5s
Copyright Thomson Reuters


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: %s via Thomson Reuters ONE


[HUG#1619746]